Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (formaldehyde inactivated)

DB14587ApprovedInvestigationalVaccines

Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (formaldehyde inactivated) is an inactivated antigen of influenza used in seasonal influenza vaccines. A seasonally-specific component of the influenza vaccine.

First approval
United States, 2018
Brand names
  • Fluzone High-dose
  • Fluzone Quadrivalent

Resolves to

Compound
UNIIKMO6TK08J4

What you can answer from here — as of April 02, 2025

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
13ContraindicationsEach with its own population and attribute set
Sign in
16Marketed productsAcross 5 countries and 5 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In